Logo image of BFRI

BIOFRONTERA INC (BFRI) Stock Analyst Ratings

USA - NASDAQ:BFRI - US09077D2099 - Common Stock

1.1 USD
-0.03 (-2.65%)
Last: 10/24/2025, 8:10:42 PM
1.135 USD
+0.03 (+3.18%)
After Hours: 10/24/2025, 8:10:42 PM
Buy % Consensus

83

ChartMill assigns a Buy % Consensus number of 83% to BFRI. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 6.63. This target is 502.73% above the current price.
BFRI was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about BFRI.
In the previous month the buy percentage consensus was at a similar level.
BFRI was analyzed by 8 analysts. More opinions would make the average more meaningful.
BFRI Historical Analyst RatingsBFRI Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -46 -42 -38 -34 -30 -26 -22 -18 -14 -10 -6 -2 2 4 6

Price Target & Forecast

Price Low Median Mean High 1.103.036.636.6310.50 - 175.45% 502.73% 502.73% 854.55%
BFRI Current Analyst RatingBFRI Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4
Up and Down Grades
Date Firm Action Rating
2025-05-19 Benchmark Maintains Buy -> Buy
2024-11-15 Benchmark Reiterate Buy -> Buy
2024-08-16 Benchmark Reiterate Buy -> Buy
2023-08-31 Benchmark Reiterate Buy -> Buy
2023-07-05 Benchmark Maintains Buy -> Buy
2023-05-15 Benchmark Reiterate Buy -> Buy
2023-03-09 Benchmark Reiterate Buy
2023-01-31 Benchmark Reiterate Buy
2021-12-15 Benchmark Initiate Buy
2021-11-24 Roth Capital Initiate Buy

BIOFRONTERA INC / BFRI FAQ

What is the price target for BFRI stock?

8 analysts have analysed BFRI and the average price target is 6.63 USD. This implies a price increase of 502.73% is expected in the next year compared to the current price of 1.1.


What is the consensus rating for BIOFRONTERA INC (BFRI) stock?

The consensus rating for BIOFRONTERA INC (BFRI) is 82.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.